U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H13N3.C8H6O4
Molecular Weight 377.3933
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIPHENYLGUANIDINE PHTHALATE

SMILES

OC(=O)C1=CC=CC=C1C(O)=O.N=C(NC2=CC=CC=C2)NC3=CC=CC=C3

InChI

InChIKey=JSCFNQDWXBNVBP-UHFFFAOYSA-N
InChI=1S/C13H13N3.C8H6O4/c14-13(15-11-7-3-1-4-8-11)16-12-9-5-2-6-10-12;9-7(10)5-3-1-2-4-6(5)8(11)12/h1-10H,(H3,14,15,16);1-4H,(H,9,10)(H,11,12)

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/11965241

Diphenylguanidine (DPG) has been used as a primary and secondary accelerator in the vulcanization of rubber. Exposure to DPG may occur as a result of dermal contact during rubber manufacture or from contact with the finished products. DPG is poorly absorbed through skin. It can be found in latex gloves and other rubber products found in homes and offices. Diphenylguanidine is a standardized chemical allergen. It is used for diagnosis of contact allergy. It is a component of Carba Mix, used in the epicutaneous patch test, called T.R.U.E. TEST, approved by FDA in 1994. T.R.U.E. TEST is indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
T.R.U.E. TEST

Approved Use

T.R.U.E. TEST is an epicutaneous patch test indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels.

Launch Date

1993
PubMed

PubMed

TitleDatePubMed
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
2011-07-14
Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.
2011-05-01
Allergic contact dermatitis to synthetic rubber gloves: changing trends in patch test reactions to accelerators.
2010-09
Lymphomatoid allergic contact dermatitis mimicking cutaneous T cell lymphoma.
2010-07-22
An 8-year retrospective review of patch testing with rubber allergens: the Mayo Clinic experience.
2010-02-09
Study of molecularly imprinted solid-phase extraction of diphenylguanidine and its structural analogs.
2009-04-20
A novel reactivity mode for metal-activated dialkylcyanamide species: addition of N,N'-diphenylguanidine to a cis-(R2NCN)2Pt(II) center giving an eight-membered chelated platinaguanidine.
2009-03-16
Novel tailoring reaction for two adjacent coordinated nitriles giving platinum 1,3,5-triazapentadiene complexes.
2008-12-15
Identification of an unknown extraneous contaminant in pharmaceutical product analysis.
2007-12-21
Glove allergy due to 1,3-diphenylguanidine.
2006-01
Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG).
2005-04
Occupational rubber glove allergy: results of the Information Network of Departments of Dermatology (IVDK), 1995-2001.
2003-01
Patents

Sample Use Guides

Apply the three adhesive panels of allergens and allergen mixes on healthy skin of the back. Remove panels and evaluate the skin 48 hours after application. Re-evaluate the skin 72 to 96 hours after application.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Name Type Language
PHTHALIC ACID, COMPD. WITH 1,3-DIPHENYLGUANIDINE (1:1)
Preferred Name English
DIPHENYLGUANIDINE PHTHALATE
Systematic Name English
GUANIDINE, 1,3-DIPHENYL-, PHTHALATE (1:1)
Systematic Name English
1,2-BENZENEDICARBOXYLIC ACID, COMPD. WITH N,N'-DIPHENYLGUANIDINE (1:1)
Systematic Name English
GUANIDINE, N,N'-DIPHENYL-, 1,2-BENZENEDICARBOXYLATE (1:1)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID60612123
Created by admin on Mon Mar 31 23:02:13 GMT 2025 , Edited by admin on Mon Mar 31 23:02:13 GMT 2025
PRIMARY
CAS
17573-13-6
Created by admin on Mon Mar 31 23:02:13 GMT 2025 , Edited by admin on Mon Mar 31 23:02:13 GMT 2025
PRIMARY
FDA UNII
QN8EL2P69Q
Created by admin on Mon Mar 31 23:02:13 GMT 2025 , Edited by admin on Mon Mar 31 23:02:13 GMT 2025
PRIMARY
PUBCHEM
22497391
Created by admin on Mon Mar 31 23:02:13 GMT 2025 , Edited by admin on Mon Mar 31 23:02:13 GMT 2025
PRIMARY